LMS announces Bankruptcy Act filing



    /NOT FOR DISTRIBUTION TO US NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE
    UNITED STATES OF AMERICA/

    MONTREAL, June 4 /CNW Telbec/ - LMS Medical Systems (TSX:LMZ)("the
"Company") announced today that it, and its subsidiary LMS Medical Systems
(Canada) Ltd., have each filed a Notice of Intention to Make a Proposal under
the Bankruptcy and Insolvency Act (Canada). These filings effect an initial
30-day stay of proceedings against all creditors of the companies, during
which the companies must file a proposal with the court. The implications for
creditors and other stakeholders of the companies is not known at this time
and will not be known until the restructuring process is complete.

    Samson Bélair / Deloitte & Touche Inc. have been appointed by both
companies as trustee.

    The Company also announced that Benoit La Salle has resigned as a
director of the Company. The Company's other current directors will continue
to constitute the Company's board of directors.

    About LMS: LMS is a leader in the application of advanced mathematical
modeling and neural networks for medical use. The LMS CALM Suite provides
physicians, nursing staff, risk managers and hospital administrators with
clinical information systems and risk management tools designed to improve
outcomes and patient care for mothers and their infants during childbirth.

    Except for historical information contained herein, the matters discussed
in this news release are forward-looking statements. Because these
forward-looking statements involve risks and uncertainties, there are
important factors that could cause actual results to differ materially from
those expressed implied by the forward-looking statements including, but
without limitation, economic conditions in general and in the healthcare
market, the demand for and market for our products in domestic and
international markets, our current dependence on the CALM product suite, the
challenges associated with developing new products and obtaining regulatory
approvals if necessary, research and development activities, the uncertainty
of acceptance of our products by the medical community, the lengthy sales
cycle for our products, third party reimbursement, competition in our markets,
including the potential introduction of competitive products by others, our
dependence on our distributors, physician training, enforceability and the
costs of enforcement of our patents, potential infringements of our patents
and the other factors set forth from time to time in the Company's filings
with the United States Securities and Exchange Commission and with the
Canadian Securities Commissions. The Company has no intention of or obligation
to update or revise any forward-looking statements, whether as a result of new
information, future events or otherwise.




For further information:

For further information: William Horn, CEO/CFO, LMS Medical Systems
Ltd., (514) 488-3461, Fax: (514) 488-1880; Philippe Jordan, CMA, CIRP,
Trustee, Samson Bélair/Deloitte & Touche Inc., (514) 393-8386, Fax: (514)
390-4103

Organization Profile

LMS MEDICAL SYSTEMS INC.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890